Skip to main content

A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.

Publication ,  Conference
Secord, AA; Havrilesky, LJ; Higgins, RV; Nycum, LR; Kohler, MF; Puls, LE; Holloway, R; Soper, JT; Valea, FA; Berchuck, A
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 20, 2006

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

278S / 278S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Secord, A. A., Havrilesky, L. J., Higgins, R. V., Nycum, L. R., Kohler, M. F., Puls, L. E., … Berchuck, A. (2006). A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 24, pp. 278S-278S). Atlanta, GA: AMER SOC CLINICAL ONCOLOGY.
Secord, A Alvarez, L. J. Havrilesky, R. V. Higgins, L. R. Nycum, M. F. Kohler, L. E. Puls, R. Holloway, J. T. Soper, F. A. Valea, and A. Berchuck. “A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.” In JOURNAL OF CLINICAL ONCOLOGY, 24:278S-278S. AMER SOC CLINICAL ONCOLOGY, 2006.
Secord AA, Havrilesky LJ, Higgins RV, Nycum LR, Kohler MF, Puls LE, et al. A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 278S-278S.
Secord, A. Alvarez, et al. “A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.JOURNAL OF CLINICAL ONCOLOGY, vol. 24, no. 18, AMER SOC CLINICAL ONCOLOGY, 2006, pp. 278S-278S.
Secord AA, Havrilesky LJ, Higgins RV, Nycum LR, Kohler MF, Puls LE, Holloway R, Soper JT, Valea FA, Berchuck A. A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2006. p. 278S-278S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

June 20, 2006

Volume

24

Issue

18

Start / End Page

278S / 278S

Location

Atlanta, GA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

42nd Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences